Advertisement

Supportive Care in Cancer

, Volume 27, Issue 3, pp 1071–1079 | Cite as

Endurance and resistance training in patients with acute leukemia undergoing induction chemotherapy—a randomized pilot study

  • Anja WehrleEmail author
  • Sarah Kneis
  • Hans-Hermann Dickhuth
  • Albert Gollhofer
  • Hartmut Bertz
Original Article

Abstract

Purpose

Acute leukemia (AL) and its initial treatment can impair physical functioning and capacity significantly. Exercise as a countermeasure has been investigated in few studies confirming its feasibility and safety during intensive induction chemotherapy, but the relative effects of diverse exercise programs have not been analyzed. Therefore, we aimed to investigate independent effects of endurance and resistance training on physical capacity and quality of life (QOL).

Methods

Twenty-nine adult AL patients were randomly allocated to an endurance (EG), resistance (RG), or control (CG) group. The intervention took place during induction chemotherapy with three exercise sessions per week for 30–45 min each. Endurance capacity at individual anaerobic threshold, maximum knee extension and flexion strength, standardized phase angle (SPA), and QOL were measured at baseline prior to induction chemotherapy and before discharge.

Results

Endurance capacity changed in neither the EG, RG, or CG (P = 0.104); descriptively, the EG (− 0.05 W/kg) and RG (− 0.04 W/kg) exhibited a smaller decrease than CG (− 0.22 W/kg). We noted a significant difference in knee extension strength (P = 0.002); RG improved their maximum strength (+ 0.14 Nm/kg), while the EG’s (− 0.13 Nm/kg) and CG’s (− 0.19 Nm/kg) was significantly reduced. QOL and SPA revealed no change after the intervention.

Conclusions

We conclude that resistance training is a key component when exercising during induction chemotherapy: it improved maximum strength, but also influenced endurance capacity even during intensive treatment. Considering the prognostic value of physical function, we strongly propose integrating exercise, especially resistance-based training, already during induction chemotherapy to preserve AL patients’ physical capacity and functional status.

Keywords

Hematologic neoplasms Hospitalization Exercise therapy Muscle strength Physical endurance Quality of life 

Notes

Acknowledgements

We thank all patients who participated in this study. We are grateful to Carole Cürten (English Copy Editor) for proofreading our manuscript and we thank Manfred Baumstark for statistical assistance.

Funding

This trial was supported by Baden-Württemberg foundation.

Compliance with ethical standards

All patients gave written informed consent for the study protocol and data collection; this pilot study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Commission of the University of Freiburg, Germany.

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Deschler B, Ihorst G, Platzbecker U, Germing U, Marz E, de Figuerido M, Fritzsche K, Haas P, Salih HR, Giagounidis A, Selleslag D, Labar B, de Witte T, Wijermans P, Lubbert M (2013) Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome. Haematologica 98:208–216.  https://doi.org/10.3324/haematol.2012.067892 CrossRefGoogle Scholar
  2. 2.
    Redaelli A, Stephens JM, Brandt S, Botteman MF, Pashos CL (2004) Short- and long-term effects of acute myeloid leukemia on patient health-related quality of life. Cancer Treat Rev 30:103–117.  https://doi.org/10.1016/S0305-7372(03)00142-7 CrossRefGoogle Scholar
  3. 3.
    Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, Stein KD, Alteri R, Jemal A (2016) Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin 66:271–289.  https://doi.org/10.3322/caac.21349 CrossRefGoogle Scholar
  4. 4.
    Klepin HD (2016) Definition of unfit for standard acute myeloid leukemia therapy. Curr Hematol Malig Rep 11:537–544.  https://doi.org/10.1007/s11899-016-0348-8 CrossRefGoogle Scholar
  5. 5.
    Schmitz KH, Courneya KS, Matthews C, Demark-Wahnefried W, Galvão DA, Pinto BM, Irwin ML, Wolin KY, Segal RJ, Lucia A, Schneider CM, von Gruenigen V, Schwartz AL, American College of Sports Medicine (2010) American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 42:1409–1426.  https://doi.org/10.1249/MSS.0b013e3181e0c112 CrossRefGoogle Scholar
  6. 6.
    Smith-Turchyn J, Richardson J (2015) A systematic review on the use of exercise interventions for individuals with myeloid leukemia. Support Care Cancer 23:2435–2446.  https://doi.org/10.1007/s00520-015-2752-3 CrossRefGoogle Scholar
  7. 7.
    Bergenthal N, Will A, Streckmann F et al (2014) Aerobic physical exercise for adult patients with haematological malignancies. Cochrane Database Syst Rev (11):CD009075Google Scholar
  8. 8.
    Battaglini CL (2011) Physical activity and hematological cancer survivorship. Recent Results Cancer Res 186:275–304.  https://doi.org/10.1007/978-3-642-04231-7_12 CrossRefGoogle Scholar
  9. 9.
    Bryant AL, Deal AM, Battaglini CL, Phillips B, Pergolotti M, Coffman E, Foster MC, Wood WA, Bailey C, Hackney AC, Mayer DK, Muss HB, Reeve BB (2017) The effects of exercise on patient-reported outcomes and performance-based physical function in adults with acute leukemia undergoing induction therapy: exercise and quality of life in acute leukemia (EQUAL). Integr Cancer Ther 17:263–270.  https://doi.org/10.1177/1534735417699881 CrossRefGoogle Scholar
  10. 10.
    Alibhai SMH, Durbano S, Breunis H, Brandwein JM, Timilshina N, Tomlinson GA, Oh PI, Culos-Reed SN (2015) A phase II exercise randomized controlled trial for patients with acute myeloid leukemia undergoing induction chemotherapy. Leuk Res 39:1178–1186.  https://doi.org/10.1016/j.leukres.2015.08.012 CrossRefGoogle Scholar
  11. 11.
    Alibhai SMH, O’Neill S, Fisher-Schlombs K, Breunis H, Brandwein JM, Timilshina N, Tomlinson GA, Klepin HD, Culos-Reed SN (2012) A clinical trial of supervised exercise for adult inpatients with acute myeloid leukemia (AML) undergoing induction chemotherapy. Leuk Res 36:1255–1261.  https://doi.org/10.1016/j.leukres.2012.05.016 CrossRefGoogle Scholar
  12. 12.
    Klepin HD, Danhauer SC, Tooze JA, Stott K, Daley K, Vishnevsky T, Powell BL, Mihalko SL (2011) Exercise for older adult inpatients with acute myelogenous leukemia: a pilot study. J Geriatr Oncol 2:11–17.  https://doi.org/10.1016/j.jgo.2010.10.004 CrossRefGoogle Scholar
  13. 13.
    Battaglini CL, Hackney AC, Garcia R, Groff D, Evans E, Shea T (2009) The effects of an exercise program in leukemia patients. Integr Cancer Ther 8:130–138.  https://doi.org/10.1177/1534735409334266 CrossRefGoogle Scholar
  14. 14.
    Chang P-H, Lai Y-H, Shun S-C, Lin LY, Chen ML, Yang Y, Tsai JC, Huang GS, Cheng SY (2008) Effects of a walking intervention on fatigue-related experiences of hospitalized acute myelogenous leukemia patients undergoing chemotherapy: a randomized controlled trial. J Pain Symptom Manag 35:524–534.  https://doi.org/10.1016/j.jpainsymman.2007.06.013 CrossRefGoogle Scholar
  15. 15.
    Padilha CS, Marinello PC, Galvão DA, Newton RU, Borges FH, Frajacomo F, Deminice R (2017) Evaluation of resistance training to improve muscular strength and body composition in cancer patients undergoing neoadjuvant and adjuvant therapy: a meta-analysis. J Cancer Surviv 11:339–349.  https://doi.org/10.1007/s11764-016-0592-x CrossRefGoogle Scholar
  16. 16.
    Coyle EF, Martin WH, Ehsani AA, Hagberg JM, Bloomfield SA, Sinacore DR, Holloszy JO (1983) Blood lactate threshold in some well-trained ischemic heart disease patients. J Appl Physiol 54:18–23CrossRefGoogle Scholar
  17. 17.
    Gupta D, Lammersfeld CA, Burrows JL, Dahlk SL, Vashi PG, Grutsch JF, Hoffman S, Lis CG (2004) Bioelectrical impedance phase angle in clinical practice: implications for prognosis in advanced colorectal cancer. Am J Clin Nutr 80:1634–1638CrossRefGoogle Scholar
  18. 18.
    Paiva SI, Borges LR, Halpern-Silveira D, Assunção MCF, Barros AJD, Gonzalez MC (2011) Standardized phase angle from bioelectrical impedance analysis as prognostic factor for survival in patients with cancer. Support Care Cancer 19:187–192CrossRefGoogle Scholar
  19. 19.
    Schwenk A, Beisenherz A, Romer K et al (2000) Phase angle from bioelectrical impedance analysis remains an independent predictive marker in HIV-infected patients in the era of highly active antiretroviral treatment. Am J Clin Nutr 72:496–501CrossRefGoogle Scholar
  20. 20.
    Urbain P, Birlinger J, Ihorst G, Biesalski HK, Finke J, Bertz H (2013) Body mass index and bioelectrical impedance phase angle as potentially modifiable nutritional markers are independent risk factors for outcome in allogeneic hematopoietic cell transplantation. Ann Hematol 92:111–119.  https://doi.org/10.1007/s00277-012-1573-4 CrossRefGoogle Scholar
  21. 21.
    Bosy-Westphal A, Danielzik S, Dörhöfer R-P, Later W, Wiese S, Müller MJ (2006) Phase angle from bioelectrical impedance analysis: population reference values by age, sex, and body mass index. JPEN J Parenter Enteral Nutr 30:309–316.  https://doi.org/10.1177/0148607106030004309 CrossRefGoogle Scholar
  22. 22.
    Fayers P, Bottomly A (2002) Quality of life research within the EORTC— the EORTC QLQ-C30. Eur J Cancer 38:125–133CrossRefGoogle Scholar
  23. 23.
    Frey I, Berg A, Grathwohl D, Keul J (1999) Freiburger Fragebogen zur körperlichen Aktivität-Entwicklung, Prüfung und Anwendung. Soz- Präventivmedizin SPM 44:55–64.  https://doi.org/10.1007/BF01667127 CrossRefGoogle Scholar
  24. 24.
    Dimeo F, Schwartz S, Wesel N, Voigt A, Thiel E (2008) Effects of an endurance and resistance exercise program on persistent cancer-related fatigue after treatment. Ann Oncol 19:1495–1499.  https://doi.org/10.1093/annonc/mdn068 CrossRefGoogle Scholar
  25. 25.
    Knols R, Aaronson NK, Uebelhart D, Fransen J, Aufdemkampe G (2005) Physical exercise in cancer patients during and after medical treatment: a systematic review of randomized and controlled clinical trials. JClinOncol 23:3830–3842CrossRefGoogle Scholar
  26. 26.
    Borg G (1982) Psychophysical bases of perceived exertion. Med Sci Sports Exerc 14:377–381Google Scholar
  27. 27.
    Julious SA (2005) Sample size of 12 per group rule of thumb for a pilot study. Pharm Stat 4:287–291.  https://doi.org/10.1002/pst.185 CrossRefGoogle Scholar
  28. 28.
    Barbosa-Silva MCG, Barros AJD (2005) Bioelectrical impedance analysis in clinical practice: a new perspective on its use beyond body composition equations. Curr Opin Clin Nutr Metab Care 8:311–317CrossRefGoogle Scholar
  29. 29.
    Norman K, Stobäus N, Zocher D, Bosy-Westphal A, Szramek A, Scheufele R, Smoliner C, Pirlich M (2010) Cutoff percentiles of bioelectrical phase angle predict functionality, quality of life, and mortality in patients with cancer. Am J Clin Nutr 92:612–619.  https://doi.org/10.3945/ajcn.2010.29215 CrossRefGoogle Scholar
  30. 30.
    Rao AV (2016) Fitness in the elderly: how to make decisions regarding acute myeloid leukemia induction. Hematol Am Soc Hematol Educ Program 2016:339–347.  https://doi.org/10.1182/asheducation-2016.1.339 CrossRefGoogle Scholar
  31. 31.
    Wedding U, Röhrig B, Klippstein A, Fricke HJ, Sayer HG, Höffken K (2006) Impairment in functional status and survival in patients with acute myeloid leukaemia. J Cancer Res Clin Oncol 132:665–671.  https://doi.org/10.1007/s00432-006-0115-7 CrossRefGoogle Scholar
  32. 32.
    Hickson RC, Marone JR (1993) Exercise and inhibition of glucocorticoid-induced muscle atrophy. Exerc Sport Sci Rev 21:135–167CrossRefGoogle Scholar
  33. 33.
    LaPier TK (1997) Glucocorticoid-induced muscle atrophy. The role of exercise in treatment and prevention. J Cardiopulm Rehabil 17:76–84CrossRefGoogle Scholar
  34. 34.
    Adamsen L, Quist M, Midtgaard J, Andersen C, Møller T, Knutsen L, Tveterås A, Rorth M (2006) The effect of a multidimensional exercise intervention on physical capacity, well-being and quality of life in cancer patients undergoing chemotherapy. Support Care Cancer 14:116–127CrossRefGoogle Scholar
  35. 35.
    Kuehl R, Scharhag-Rosenberger F, Schommer K et al (2015) Exercise intensity classification in cancer patients undergoing allogeneic HCT. Med Sci Sports Exerc 47:889–895.  https://doi.org/10.1249/MSS.0000000000000498 CrossRefGoogle Scholar
  36. 36.
    Faude O, Kindermann W, Meyer T (2009) Lactate threshold concepts: how valid are they? Sports Med Auckl NZ 39:469–490CrossRefGoogle Scholar
  37. 37.
    Roecker K (2013) Die sportmedizinische Laktatdiagnostik: Technische Rahmenbedingungen und Einsatzbereiche. Dtsch Z Für Sportmed 64:367–371Google Scholar
  38. 38.
    Scharhag-Rosenberger F, Becker T, Streckmann F et al (2014) Studien zu körperlichem Training bei onkologischen Patienten: Empfehlungen zu den Erhebungsmethoden. Dtsch Z Für Sportmed 65:304–313CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Institute for Exercise- and Occupational Medicine, Medical Center – University of Freiburg, Faculty of MedicineUniversity of FreiburgFreiburgGermany
  2. 2.Department of Medicine I (Specialties: Hematology, Oncology, and Stem-Cell Transplantation), Medical Center – University of Freiburg, Faculty of MedicineUniversity of FreiburgFreiburgGermany
  3. 3.Department of Sport and Sport ScienceUniversity of FreiburgFreiburgGermany

Personalised recommendations